Gut Microbial Metabolite Suppresses Colorectal Cancer Growth in Preclinical Models
In preclinical models, gut bacteria producing the cholesterol metabolite 4-cholesten-3-one suppressed colorectal cancer growth and overcame resistance to targeted therapy.

